Hanmi Pharm. Co., Ltd.
128940
Clasificación en acciones
#4358
A globally active pharmaceutical company, Hanmi Pharm. Co., Ltd. was... A globally active pharmaceutical company, Hanmi Pharm. Co., Ltd. was established in Seoul, South Korea, in 1973. The firm concentrates its efforts on researching and developing medical therapies for a range of health issues, including diabetes, obesity, cancer, autoimmune disorders, and various rare diseases.
Precio por acción
$279.16
Capitalización bursátil
$3.54B
Cambio (1 día)
-2.37%
Cambio (1 año)
14.50%
País
KR
Comercio Hanmi Pharm. Co., Ltd. (128940)
Categoría
Healthcare
Ganancias de Hanmi Pharm. Co., Ltd. (128940)
Ganancias en Jun 2026 TTM: $215.70M
Secondo gli ultimi rapporti finanziari di Hanmi Pharm. Co., Ltd., gli utili attuali della società sono $215.70M. Nel 2024, la società ha registrato un utile di $116.49M, una disminución en comparación con agli utili del 2023, che erano di $149.84M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Hanmi Pharm. Co., Ltd. desde 2010 hasta 2026
Ganancias al final de cada año
| Año | Ganancias | Cambiar |
|---|---|---|
| 2026 (TTM) | $215.70M | 47.71% |
| 2025 | $146.03M | 25.36% |
| 2024 | $116.49M | -22.26% |
| 2023 | $149.84M | 56.25% |
| 2022 | $95.90M | 9.95% |
| 2021 | $87.22M | 327.88% |
| 2020 | $20.38M | -71.73% |
| 2019 | $72.11M | 59.46% |
| 2018 | $45.22M | -18.10% |
| 2017 | $55.22M | 732.49% |
| 2016 | $6.63M | -96.28% |
| 2015 | $178.34M | 435.24% |
| 2014 | $33.32M | -36.02% |
| 2013 | $52.08M | 72.15% |
| 2012 | $30.25M | 443.59% |
| 2011 | $5.57M | -147.87% |
| 2010 | $-11.63M | 0.00% |
Ganancias de empresas similares o competidoras
| Empresa | Ganancias | Diferencia de ganancias | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| $1.72B | 699.10% |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 718.07% |
IN
|
